Doug Hampton ST. LOUIS, May 12, 2023 /PRNewswire/ — Centene Corporation (NYSE: CNC) announced today it will present at the Bernstein 39th Annual Strategic Decisions Conference, to be held Wednesday, May 31-Friday, June 2, 2023, in New York City. Centene will present on Thursday, June 1st at 9:00 a.m. Eastern Time (ET). A simultaneous live audio webcast … Read more
SILVER SPRING, Md., May 12, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA updated information on medical device shortages on the FDA.gov website to reflect the end of the COVID-19 public health emergency (PHE), including providing answers to questions, … Read more
HOUSTON, May 12, 2023 /PRNewswire/ — Today, FemTec Health, Inc. announced the purchase of its Birchbox assets, effective April 12, 2023, by Retention Brands. Early this year as part of its strategic tightening around core healthcare businesses, FemTec Health engaged a national financial consulting firm to advise and explore possibilities for the sale of some of … Read more
SHANGHAI, May 12, 2023 /PRNewswire/ — LaNova Medicines Ltd. (“LaNova Medicines”) announced today it has entered into an exclusive license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN), for LM-305, a pre-clinical stage antibody drug conjugate (ADC) targeting G protein-coupled receptor, class C, group 5, member D (GPRC5D). Under the terms of the licensing agreement, AstraZeneca will be … Read more
Organization recognizes and celebrates efforts of child care providers ARLINGTON, Va., May 12, 2023 /PRNewswire/ — Child Care Aware® of America (CCAoA) today celebrates Provider Appreciation Day® alongside states and communities across the country. Provider Appreciation Day is celebrated the Friday before Mother’s Day every year to recognize child care providers, teachers and other … Read more
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause TOKYO, May 12, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that the U.S. Food and Drug Administration (FDA) has approved VEOZAHTM (fezolinetant) 45 mg once daily for … Read more
the essential The collective against air pollution of the Toulouse conurbation and several associations were joined for a demonstration, by elected representatives from the left. They are asking for a cap on the number of annual flights at Toulouse Blagnac airport, and a curfew at night. “We don’t want so many planes over our heads … Read more
SILVER SPRING, Md., May 12, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause. Veozah is the first neurokinin 3 (NK3) receptor antagonist approved by the FDA to treat moderate to severe hot flashes … Read more
DUBLIN, May 12, 2023 /PRNewswire/ — The “Industrial Cleaning Chemicals Market by Ingredient (Surfactants, Solvents, Chelating Agents), Product (General & Medical Cleaning), Application (Manufacturing & Commercial Offices, Healthcare, Retail & Food Service), and Region – Global Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The industrial cleaning chemicals market is projected to grow … Read more
JINAN, China, 12. Mai 2023 /PRNewswire/ — Am 8. Mai 2023 veröffentliche das Journal of Hematology & Oncology (JHO, 2022 Impact Factor von 23.168) die Ergebnisse der klinischen Phase-I-Studie des bifunktionalen Immuntherapie-Antikörpers QL1706 von Qilu Pharma (J Hematol Oncol 8. Mai 2023;16(1):50). Diese Studie ist die erste große klinische Phase-I-Studie mit QL1706 am Menschen und … Read more